GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for polyribonucleotide nucleotidyltransferase (B9MEL0)

Analyse AlphaFold monomer V2.0 prediction for polyribonucleotide nucleotidyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B9MEL0
Type
protein
Length
727 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xd92eb9B6Bd45d2c5FBB3651b469A6CA52af64a1D
Molecule
Polyribonucleotide nucleotidyltransferase
UniProt
B9MEL0
Pockets
4 · best druggability 0.76

Structure

1 distinct chain · 33% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolyribonucleotide nucleotidyltransferaseprotein72733% helix, 28% strandB9MEL0

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19530.760.7988empty
210340.710.7587empty
3650.430.8114empty
4660.330.7616empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.